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ABSTRACT
Background and aims: Autoimmune pancreatitis (AIP)
is a poorly understood human disease affecting the
exocrine pancreas. The goal of the present study was to
elucidate the pathogenic mechanisms underlying pan-
creatic autoimmunity in a murine disease model.
Methods: A transgenic mouse with an S100A4/
fibroblast-specific protein 1 (FSP1) Cre-mediated condi-
tional knockout of the transforming growth factor b
(TGFb) type II receptor, termed Tgfbr2
fspKO, was used to
determine the direct role of TGFb in S100A4
+ cells.
Immunohistochemical studies suggested that Tgfbr2
fspKO
mice develop mouse AIP (mAIP) characterised by
interlobular ductal inflammatory infiltrates and pancreatic
autoantibody production. Fluorescence-activated cell
sorting (FACS)-isolated dendritic cells (DCs) from dis-
eased pancreata were verified to have S100A4-Cre-
mediated DNA recombination.
Results: The Tgfbr2
fspKO mice spontaneously developed
mAIP by 6 weeks of age. DCs were confirmed to express
S100A4, a previously reported protein expressed by
fibroblasts. Adoptive transfer of bone marrow-derived DCs
from Tgfbr2
fspKO mice into 2-week-old syngenic wild-type
C57BL/6 mice resulted in reproduction of pancreatitis
within 6 weeks. Similar adoptive transfer of wild-type DCs
had no effect on pancreas pathology of the host mice. The
inability to induce pancreatitis by adoptive transfer of
Tgfbr2
fspKO DCs in adult mice suggested a developmental
event in mAIP pathogenesis. Tgfbr2
fspKO DCs undergo
elevated maturation in response to antigen and increased
activation of naı ¨ve CD4-positive T cells.
Conclusion: The development of mAIP in the Tgfbr2
fspKO
mouse model illustrates the role of TGFb in maintaining
myeloid DC immune tolerance. The loss of immune
tolerance in myeloid S100A4
+ DCs can mediate mAIP and
may explain some aspects of AIP disease pathogenesis.
Autoimmunity to pancreatic antigens can result in
a number of human diseases including insulin-
dependent diabetes mellitus (IDDM) and autoim-
mune pancreatitis (AIP). While the immune
mechanisms underlying the development of
IDDM are well known, information on the
immunopathogenesis of AIP is limited.
1 The
specific pancreatic histopathology of the disease
includes dense inflammatory infiltrates composed
primarily of T cells and macrophages limited to
interlobular ducts of the exocrine pancreas.
However, AIP is one manifestation of immunoglo-
bulin G4 (IgG4)-related sclerosing disease, a sys-
temic disease characterised by periductal
lymphocytes, plasma cells and macrophage infil-
tration of various organs including the pancreas,
salivary gland, kidney, lung and prostate, with
cellularandstoriformfibrosiswithprogressiveacinar
atrophy and obliterative phlebitis.
2 While the patho-
genesis of AIP is poorly understood, it is associated
with elevated Ig levels caused by the formation of
autoantibodies against pancreatic antigens.
3
Transforming growth factor b (TGFb)i sa
pleiotropic cytokine that regulates immune func-
tion.
4 TGFb signalling requires binding to the
TGFb type II receptor (Tgfbr2) for downstream
activity. We previously reported spontaneous
development of forestomach squamous cell carci-
noma and prostatic intraepithelial neoplasia in
mice with fibroblastic conditional knockout of the
Tgfbr2 gene.
5 These mice, termed Tgfbr2
fspKO, were
developed by crossing Tgfbr2
floxE2/floxE2 mice to
transgenic mice expressing Cre recombinase driven
by the FSP-1 (fibroblast specific protein-1 or
S100A4) promoter. S100A4 expression was initially
characterised in cells of mesenchymal origin
including stromal fibroblasts and epithelial cells
undergoing epithelial–mesenchymal transdifferen-
tiation.
6 S100A4 expression was subsequently
identified in immunological tissues including
spleen and lymph nodes.
7 However, the identity
and function of immune cells expressing the
intracellular S100A4 protein have not been deter-
mined. Since TGFb signalling requires the presence
of Tgfbr2 on the cell surface,
8 cells expressing
S100A4 in Tgfbr2
fspKO mice lack the ability to
respond to TGFb. Tgfbr2
fspKO mice displayed
slowed somatic growth beginning 2 weeks after
birth and died by postnatal week 6.
5 In studying
the cause of premature death in Tgfbr2
fspKO mice,
we histologically identified pancreatitis. The data
indicate the Tgfbr2
fspKO mice develop a disease with
the pancreatic manifestations of human AIP, and
S100A4
+ myeloid dendritic cells (DCs) lacking
maturational regulation by TGFb mediate the
development of autoimmune disease.
MATERIALS AND METHODS
Animals
Mice were maintained and genotyped as previously
described.
59All animals were backcrossed at least
13 generations onto the C57BL/6 strain (Harlan
Laboratories. Indianapolis, Indiana, USA) and
housed in sterile, pathogen-free conditions. The
studies described have been reviewed and approved
by the Vanderbilt Institutional Animal Care and
Use Committee.
Immunolocalisation and b-galactosidase activity
Pancreata were fixed in 4% paraformaldehyde and
processed into paraffin blocks. H&E, Masson’s
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performed on 5 mm paraffin sections. IHC was performed by
standard de-paraffinisation and rehydration steps followed by
blocking with blocking buffer (10% fetal bovine serum (FBS) in
phosphate-buffered saline (PBS)) for 1 h. Primary antibodies
were incubated overnight at 4uC, followed by Envision-plus
antimouse or antirabbit 3-diaminobenzidine detection kits
(Dako, Carpinteria, California, USA). For determination of b-
galactosidase activity, the pancreata were fixed in 4% paraf-
ormaldehyde for 1 h, washed, and incubated in X-gal for 4 h as
previously described.
9
For determination of pancreatic autoantibody expression,
10 mm frozen sections from canine pancreatic tissues were used
to prevent non-specific staining seen with murine tissue. The
sections were incubated in blocking buffer for 1 h and then in
serum from either Tgfbr2
fspKO or Tgfbr2
floxE2/floxE2 mice for 30 min
(1:50 dilution in blocking buffer) prior to detection with
antimouse IgG Fab labelled with Alexa Fluor 595 and Hoechst
nuclear counterstain. Slides were visualised on a Nikon
Axiophot epifluorescent microscope.
Fluorescence-activated cell sorting (FACS)
Pancreas, spleen and bone marrow cells were analysed by FACS
as previously described.
10 Briefly, pancreata were harvested and
injected with 1 mg/ml collagenase P (Roche Diagnostics,
Nutley, New Jersey, USA) in Hank’s balanced salt solution
(HBSS) followed by incubation in collagenase solution for
30 min at 37uC with agitation.
10 After digestion, the tissue was
drawn through an 18-gauge needle several times to dissociate
the cells prior to FACS analysis.
Cells (1610
6 live cells) were blocked using anti-Fc antibody
(Abcam, Cambridge, Massachusetts, USA) and stained in PBS
containing 3% FBS and 2.5% sodium azide. 7-Actinomycin D (7-
AAD) at 10 ng/ml (Sigma-Aldrich, St Louis, Missouri, USA) was
added during antibody incubation to identify dead cells. Singly
labelled cell aliquots along with cells stained with fluorochrome-
labelled rat isotype control antibodies (BD Pharmingen, Franklin
Lakes, New Jersey, USA) were used as compensation and
negative staining controls, respectively. The Cytofix/Cytoperm
Plus kit (BD Pharmingen) was used to identify intracellular
S100A4 expression. Biotinylated S100A4 primary antibody
(provided by Dr Eric Neilson, Vanderbilt University) was used
with streptavidin-conjugated fluorescent dye. Labelled cells
were analysed using a FACSCalibur flow cytometer (BD
Biosciences). FACS data were analysed using WinMDI software
(J Trotter, Scripps Institute, San Diego, California, USA).
Numbers in each quadrant indicate mean percentage of cells
(SD) from three replicate experiments performed using SPSS
16.0 (SPSS, Chicago, Illinois, USA).
CD11c-positive pancreatic cells were isolated by FACS
(FACSAria, BD Biosciences) from Tgfbr2
fspKO mice and
Tgfbr2
floxE2/floxE2 littermate controls. Genomic DNA was isolated
fromcellaliquotsusing anExtract-N-AmpTissuePCRkit(Sigma-
Aldrich). PCR was conducted using sense (59-AGGTGTAGA
GAAGGCACTTAGC-39) and antisense (59-CTAATCGCCAT
CTTCCAGCAGG-39) primers to identify cells that had under-
gone recombination of the Tgfbr2 gene. DNA isolated from mouse
ear clippings of Tgfbr2
fspKO and Tgfbr2
floxE2/floxE2 mice were used as
positive and negative controls, respectively.
Generation of bone marrow-derived DCs
Myeloid DCs were generated as described by Lutz et al.
11 Briefly,
the flushed bone marrow cells, depleted of red blood cells, were
plated in complete RPMI (containing 10% fetal calf serum,
55 mM 2-mercaptoethanol, 100 U/ml penicillin G sodium,
100 mg/ml streptomycin sulfate, 0.01 M HEPES and 0.08 M L-
glutamine (Invitrogen, Grand Island, New York, USA)) with
Figure 1 Tgfbr2
fspKO mice develop
pancreatitis. Representative views of
H&E-stained pancreatic tissue from
Tgfbr2
floxE2/floxE2 and Tgfbr2
fspKO mice
showing low and high power views
(n=20, scale bar represents 20 and
10 mm respectively). (B) Masson’s
trichrome staining of collagen suggests
minimal fibrotic reaction in the
pancreatitis tissues of Tgfbr2
fspKO mice
(n=6, scale bar represents 20 mm).
(C) Phosphorylated Smad-2
immunohistochemistry indicates loss of
transforming growth factor b (TGFb)
signalling in the areas of pancreatitis in
Tgfbr2
fspKO mice (arrows; n=6, scale bar
represents 10 mm).
Figure 2 Pancreatitis in Tgfbr2
fspKO mice resembles human autoimmune
pancreatitis (AIP). Representative immunohistochemistry stains of
pancreas from Tgfbr2
fspKO mice using antibodies against (A) F4/80
(macrophage), (B) CD3 (T cells), (C) nestin (stellate cells) and (D) insulin
(n=6, scale bar represents 10 mm). Asterisks indicate islets and arrows
indicate areas of pancreatitis. Arrowheads indicate nestin-positive cells.
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ing factor (GM-CSF; PeproTech, Rocky Hill, New Jersey, USA).
Following 10 days of culturing, non-adherent DCs for use in
experiments were removed from cultures by vigorous pipetting
and used for experiments after DC purity was insured by FACS.
Generation of DC chimeric mice
Bone marrow-derived DCs from Tgfbr2
fspKO mice and
Tgfbr2
floxE2/floxE2 littermate controls were produced as above and
washed twice in PBS prior to suspension in PBS at a
concentration of 1610
7 cells/ml. Two independent experiments
were conducted wherein 1610
6 bone marrow-derived DCs from
either Tgfbr2
fspKO or Tgfbr2
floxE2/floxE2 mice were injected into the
peritoneal space of either 2-week-old or adult syngeneic C57BL/
6 mice using an insulin syringe in 100 ml of PBS (n=12).
Pancreata from all mice were harvested 6 weeks later and
examined histologically.
DC maturation evaluation
Bone marrow-derived DCs from Tgfbr2
fspKO and Tgfbr2
floxE2/floxE2
littermate control mice were generated as described above. DCs
were treated overnight with 1 mg/ml lipopolysaccharide (LPS),
500 U/ml tumour necrosis factor a (TNFa)o r2 0 mg/ml
zymosan to induce maturation. A total of 1610
6 treated and
untreated DCs from each group underwent FACS as described
above for major histocompatibility complex (MHC) class II,
CD11c, CD86 (BD Pharmingen) and 7-AAD. The percentage of
mature DCs was determined for each group and treatment as
defined by cells simultaneously staining positive for CD11c and
highly positive for CD86 and MHC class II after gating out dead
(7-AAD-positive) cells. Experiments were conducted in triplicate
with results reported as mean percentage mature DCs (SD), and
one-way analysis of variance (ANOVA) was employed to
compare Tgfbr2
fspKO and Tgfbr2
floxE2/floxE2 DCs using SPSS 16.
T cell proliferation assay
Spleens from OT-II.1 transgenic mice (Jackson Laboratories, Bar
Harbor, Michigan, USA) with CD4
+ T cell receptors specific for
ovalbumin were harvested using aseptic technique, and single-
cell suspensions were made by passing tissue through a nylon
cell strainer. Red blood cells (RBCs) were lysed by Tris-
ammonium chloride treatment, and CD4
+ T cells were isolated
using a magnetic-activated cell separation (MACS) column
(Miltenyi Biotec, Auburn, Califonia, USA). T cell purity was
confirmed by FACS of presort and postsort aliquots using
fluorescence-conjugated antibodies specific for T cells (CD4), B
cells (B220) and DCs (CD11c). Initially, bone marrow-derived
DCs from Tgfbr2
fspKO and Tgfbr2
floxE2/floxE2 control mice were
incubated with ovalbumin (Sigma-Aldrich) at 100 mg/ml for
24 h prior to washing twice with PBS through centrifugation
and resuspension, and irradiation with 10 Gy of
127Cs to prevent
proliferation. Then ovalbumin-pulsed DCs were added to
100 000 OT-II.1 CD4
+ T cells in triplicate to each well of a
96-well, flat-bottomed plate (Corning, Lowell, Massachusetts,
USA) and incubated in complete RPMI. On the third day of
treatment, [
3H]thymidine incorporation assay was quantified
by scintillation counting.
12 Repeated-measures ANOVA was
used to compare change in scintillation count with DC number
between Tgfbr2
fspKO and Tgfbr2
floxE2/floxE2 DCs using SPSS 16.0.
Figure 3 Tgfbr2
fspKO mice produce
pancreatic autoantibodies. Dog pancreas
was incubated with (A) phosphate-
buffered saline or serum from (B)
Tgfbr2
floxE2/floxE2 (n=4) and (C) Tgfbr2
fspKO
mice (n=8). The immunoreactivity of the
tissues was subsequently visualised with
antimouse immunoglobulin G Fab
fragment (in red) and Hoechst nuclear
counterstain (in blue).
Figure 4 The salivary gland histology of
Tgfbr2
fspKO mice differs from that of
Tgfbr2
floxE2/floxE2 mice. The widespread
infiltration of inflammatory cells is
appreciated in the low power field.
Arrowheads indicate inflammatory cells in
the high power fields (n=6).
Pancreas
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The Tgfbr2
fspKO mouse is a murine model of AIP (mAIP)
Histological sections from pancreata of Tgfbr2
fspKO mice had
periductal, interlobular inflammatory infiltrates that were not
present in littermate control Tgfbr2
floxE2/floxE2 mice (fig 1). There
was evidence of acinar metaplasia and expansion of fibroblastic
cells periductally by 6 weeks of age without evidence for
pancreatic islet inflammatory infiltration in these mice. The
Tgfbr2
fspKO pancreata had no gross pathological differences from
the Tgfbr2
floxE2/floxE2 age-matched littermates. Masson’s tri-
chrome staining suggested no significant fibrosis, as indicated
by the lack of collagen deposition in either the Tgfbr2
fspKO or
Tgfbr2
floxE2/floxE2 pancreata. Immunolocalisation of phosphory-
lated Smad2, indicating active TGFb signalling, was seen in
pancreatic cells from both mice but was absent in inflammatory
areas of acinar metaplasia and stromal expansion in Tgfbr2
fspKO
pancreata. As in human AIP, the inflammatory infiltrates were
composed predominantly of macrophages and T cells with
sparing of the endocrine pancreas (fig 2A and B, respectively).
Further evidence for a non-fibrotic pancreatitis phenotype in
Tgfbr2
fspKO mice was demonstrated by the lack of expansion of
nestin-positive stellate cells (fig 2C). As in human AIP,
endocrine function did not seem to be overtly impaired in
Tgfbr2
fspKO mice, as determined by insulin (fig 2D) and
somatostatin expression in the islets and serum (data not
shown). Autoantibody production against pancreatic proteins is
a hallmark of human AIP.
2 To determine if Tgfbr2
fspKO mice
produced pancreatic autoantibodies, canine pancreatic tissue
was incubated with serum from either Tgfbr2
fspKO mice or
Tgfbr2
floxE2/floxE2 littermate controls. Tgfbr2
fspKO serum was found
to contain mouse antibodies against pancreatic acinar tissue
that were absent in serum from control, Tgfbr2
floxE2/floxE2 animals
(fig 3).
Human AIP can be characterised by a systemic manifestation
of the autoimmune disease associated with extrapancreatic
organ involvement. We reviewed H&E stains on lung, kidney,
salivary gland and liver. Only the salivary gland of Tgfbr2
fspKO
mice differed from those of Tgfbr2
floxE2/floxE2 control mice. Figure 4
illustrates significant inflammatory infiltration in the salivary
gland of Tgfbr2
fspKO mice that was not present in Tgfbr2
floxE2/floxE2
mice. There was global involvement of inflammatory infiltrates
associated with focal reactive metaplasia of the glandular
Figure 5 Dendritic cells (DCs) lacking
the ability to respond to transforming
growth factor b (TGFb) are present in
diseased pancreata. b-Galactosidase
activity in conjunction with
immunohistochemical stains of pancreas
from Rosa26/Tgfbr2
fspKO mice indicates
fibroblast-specific protein (FSP)-Cre-
mediated DNA recombination (A–E).
(A) b-Galactosidase activity (blue) is
associated with pancreatitis with nuclear
fast red counterstain (red). Concomitant
b-galactosidase with immunostaining
(brown) for (B) insulin, (C) F4/80 (for
macrophages), (D) CD3 (for T cells) and
(E) nestin (for stellate cells) did not
suggest DNA recombination in these cell
types. (F) PCR analysis for Cre-
recombinase activity in flow-sorted
CD11c-positive pancreatic cells from
wild-type (wt) and Tgfbr2
fspKO (KO)
suggests specific recombination in DCs
(n=6). Mouse tail DNA from Tgfbr2
fspKO
and Tgfbr2
floxE2/floxE2 mice was used as a
positive (+) and negative (2) control,
respectively.
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observed only in Tgfbr2
fspKO mice with 100% penetrance. Taken
together, these results indicate that the Tgfbr2
fspKO mouse is a
spontaneous animal model for mAIP with parallels to human
AIP at the histological level.
Myeloid DCs express S100A4
To identify specific cell type(s) knocked out for Tgfbr2 by
S100A4-Cre, Tgfbr2
fspKO mice were further crossed with Rosa26
mice. b-Galactosidase reporter activity of the pancreata from
Rosa26/Tgfbr2
fspKO mice illustrated the presence of cells positive
for Cre-mediated DNA recombination (fig 5A). Positive staining
was exclusively found in the exocrine pancreas (fig 5B), with the
suggested Tgfbr2-knockout cells co-localised to infiltrating
inflammatory cells in the pancreatic parenchyma. The lack of
co-immunostaining for F4/80, CD3 and nestin with b-galacto-
sidase activity suggested that Tgfbr2-knockout cells were not
macrophages, T cells or stellate cells, respectively (fig 5C–E).
Due to their morphology and the autoimmune nature of mAIP,
Figure 6 Splenic myeloid dendritic cells (DCs) express S100A4. Green fluorescent protein (GFP)-positive splenocytes from fibroblast-specific protein
1 (FSP1)?GFP mice simultaneously express CD11c and (A) CD11b, (B) major histocompatibilty comple (MHC) class II, (C) CD80 and (D) CD86. (E) GFP
and CD11c double-positive bone marrow-derived DCs from FSP1?GFP mice demonstrate high positivity for MHC class II and CD86 expression (numbers
in each quadrant indicate the percentage of viable cells ¡SD) (n=6).
Figure 7 Bone marrow-derived dendritic cells (DCs) express S100A4. S100A4 expression by bone marrow-derived DCs were assessed by
fluorescence-activated cell sorting (FACS) for CD11c with (A) isotype control antibody on wild-type DCs and (B) S100A4 antibody on S100A4 knockout
mice. (C) DCs from wild-type mice were double-positive for CD11c and S100A4 expression (numbers indicate the percentage of live cells in each
quadrant ¡ SD) (n=6).
Pancreas
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be myeloid DCs. Efforts to immunostain for the DC marker
CD11c on paraffin sections were unsuccessful, so the presence of
Tgfbr2-knockout DCs in disease pancreata was assessed by FACS
of pancreatic single-cell suspensions for cells expressing CD11c on
their surfaces. Cre-mediated Tgfbr2 recombination was confirmed
by PCR on the genomic DNA from the sorted pancreatic DCs
(fig5E).Thus,S100A4-positiveDCslackingTGFbregulationwere
present in the pancreata of Tgfbr2
fspKO mice.
Myeloid S100A4
+ DCs lacking TGFb regulation induce
pancreatitis
To characterise further immune cells expressing S100A4 that
could be responsible for inducing mAIP, we conducted FACS
experiments on splenocytes from FSP1?GFP (green fluoresent
protein) transgenic mice.
13 FSP1?GFP mice express GFP under
control of the S100A4 promoter,
13 and characterisation of GFP-
positive splenocytes would allow for identification of candi-
date immune cells. A population of GFP-positive cells was
found to co-express the myeloid DC markers CD11b and
CD11c (fig 6A). Further, we identified splenocytes positive for
both CD11c and GFP that expressed MHC class II and the co-
stimulatory molecules CD80 and CD86 (fig 6B–D, respectively).
We found no evidence for S100A4 expression by T cells, B cells or
macrophages using antibodies against the cell-specific markers
CD4 and CD8, B220 and F4/80, respectively (data not shown).
To identify DCs definitively, CD11c-positive cells must be
identified that simultaneous express high levels of MHC class II
and co-stimulatory molecules, as this is pathognomonic for
mature DCs.
14 However, since DCs make up only 2–3% of total
splenocytes, and only a small percentage of these DCs are
mature, confirmatory evidence for S100A4 expression by DCs
using FSP1?GFP splenocytes was limited. To overcome the
problem of low numbers of splenic mature DCs, we generated
myeloid DCs from the bone marrow of FSP1?GFP mice in vitro
by treatment with GM-CSF.
11 Bone marrow-derived S100A4-
positive myeloid DCs simultaneously expressed GFP, CD11c and
a high level of both MHC class II and CD86 (fig 6E). Intracellular
staining of similar bone marrow-derived DCs with an antibody
specific for S100A4 provided independent confirmation for
S100A4 expression by myeloid DCs (fig 7). The specificity of
the S100A4 antibody was confirmed by the observed lack of
staining in bone marrow-derived DCs from previously charac-
terised FSP1 knockout mice (fig 7B).
13
To implicate S100A4
+ DCs directly in the pathogenesis of
mAIP, bone marrow-derived DCs generated from either
Tgfbr2
fspKO or Tgfbr2
floxE2/floxE2 control mice were transferred by
intraperitoneal injection to two groups of 2-week-old syngeneic,
wild-type mice. After 6 weeks, pancreata from all mice were
harvested and examined for evidence of inflammation.
Histologically, all mice receiving Tgfbr2
fspKO DCs showed
pancreatic inflammatory infiltrates, but mice receiving
Tgfbr2
floxE2/floxE2 DCs failed to develop pancreatitis (fig 8A,B).
Development of pancreatitis was age dependent, as adult mice
Figure 8 Tgfbr2
fspKO dendritic cells (DCs) can induce autoimmune pancreatitis. Representative H&E-stained pancreatic tissue from 2-week-old wild-
type mice after transfer of bone marrow-derived DCs from (A) Tgfbr2
floxE2/floxE2 control or (B) Tgfbr2
fspKO mice (n=12). Arrows indicate areas of
inflammation. (C) Fluorescence-activated cell sorting (FACS) analysis of 1610
6 live bone marrow-derived DCs from Tgfbr2
fspKO and Tgfbr2
floxE2/floxE2 mice
before and after treatment with lipopolysaccharide (LPS) for 24 h to determine the percentage of mature DCs defined as live DCs simultaneously
expressing CD11c and high levels of CD86 and major histocompatibility complex (MHC) class II. No significant difference was seen between untreated
DCs, but LPS stimulation induced a significantly higher percentage of mature DCs in Tgfbr2
fspKO cultures (p=0.002). (D) Proliferation of OTII.1 CD4
+ T
cells stimulated with ovalbumin-pulsed bone marrow-derived DCs from Tgfbr2
fspKO and Tgfbr2
floxE2/floxE2 mice. Tgfbr2
fspKO DCs induced significantly higher
T cell proliferation with increasing DC number (p=0.05, untreated T cell control 335 (119) cpm).
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fspKO or Tgfbr2
floxE2/floxE2 DCs failed to
develop pancreatitis under similar conditions (data not shown).
Development of pancreatitis in Tgfbr2
fspKO DC chimeras
indicated that TGFb signalling in S100A4-positive myeloid
DCs is required to prevent development of mAIP and supports a
role for TGFb signalling in DC-mediated immune tolerance. The
finding that development of pancreatitis was age dependent
implicated an early pancreatic developmental event in mAIP
pathogenesis.
Tgfbr2
fspKO DCs have altered maturation resulting in increased T
cell activation
Since TGFb is known to regulate DC function and control of
DC maturation is needed to maintain immune tolerance, we
hypothesised that Tgfbr2
fspKO DCs lack normal maturational
regulation, resulting in the development of autoimmunity. To
study DC maturation, bone marrow-derived DCs from
Tgfbr2
fspKO and Tgfbr2
floxE2/floxE2 control mice were treated in vitro
with molecules that induce DC maturation, including LPS, TNFa
and zymosan. After 24 h, DCs were harvested and upregulation
of the maturation markers MHC class IIand CD86was compared
using FACS. While the number of mature DCs in untreated
Tgfbr2
floxE2/floxE2 and Tgfbr2
fspKO cultures was similar, LPS induced
maturation of Tgfbr2
fspKO DC cultures more than threefold
compared with wild type DC cultures (fig 8C). Similar results
were seen with TNFa and zymosan treatment (data not shown).
Upregulation of MHC class II and CD86 is necessary for
induction of immunity through activation of naı ¨ve T cells.
15 16
We hypothesised that mAIP occurs in Tgfbr2
fspKO mice through
overactivation of T cells by Tgfbr2
fspKO DCs. To test this
hypothesis, T cell proliferation assays were performed using
ovalbumin-stimulated bone marrow-derived DCs from
Tgfbr2
fspKO and Tgfbr2
floxE2/floxE2 control mice and naı ¨ve splenic
CD4
+ T cells from syngeneic, transgenic OT-II.1 mice that
express a single T cell receptor specific for ovalbumin.
17 DCs
from Tgfbr2
fspKO mice induced significantly more T cell
proliferation after exposure to ovalbumin than control DCs
(fig 8D). This evidence implicated increased T cell activation due
to the lack of TGFb signalling in S100A4
+ DCs as a mechanism
for loss of immune tolerance to pancreatic antigens that results
in the development of mAIP.
DISCUSSION
The present study provides evidence that TGFb regulation of
DCs mediates tolerance during pancreatic differentiation to
prevent development of pancreatic autoimmunity. The
Tgfbr2
fspKO mouse models some histological aspects of human
AIP, as Tgfbr2
fspKO mice spontaneously develop interlobular
inflammatory infiltrates of the exocrine pancreas associated
with pancreatic autoantibody production. Myeloid DCs from
both in vivo and in vitro sources were found to express
S100A4. S100A4
+ DCs were implicated in the pathogenesis of
AIP by demonstrating the presence of DCs that had undergone
Cre-mediated Tgfbr2 recombination in pancreata from
Tgfbr2
fspKO mice, and by induction of pancreatitis in wild-
type mice through transfer of DCs from Tgfbr2
fspKO mice. The
induction of pancreatitis by administration of Tgfbr2
fspKO DCs
to wild-type mice and increased Tgfbr2
fspKO DC activation of
naı ¨ v eTc e l l sp r o v i d e dd i r e c te v i d e n c ef o rt h er o l eo fT G F b in
maintaining DC immune tolerance.
Although TGFb is known to modulate DC maturity,
18 our
studies implicate disruption of TGFb signalling in DCs as a
critical event in the development of autoimmunity. DCs
normally maintain immune tolerance by remaining immature
during the presentation of self-antigens to T cells, resulting in T
cell anergy. Since Tgfbr2
fspKO DCs have increased maturation in
response to activation, we hypothesise that autoimmunity
occurs in the Tgfbr2
fspKO mouse due to precocious DC
maturation in response to self-antigen, resulting in the
activation of self-reactive T cells. Studies using targeted
disruption of Tgfbr2 in helper T cells to induce autoimmunity
are consistent with the idea that TGFb affects autoimmunity by
modulating interactions between DCs and T cells. By expressing
a dominant-negative form of Tgfbr2 under direction of the CD4
promoter, murine models of human primary biliary cirrhosis
19
and inflammatory bowel disease
20 associated with autoantibody
production have been generated. In the model of inflammatory
bowel disease, T cells were shown to evade immune tolerance
by undergoing DC-independent activation.
Our model of mAIP differs from previous DC transfer models
of autoimmune disease in that neither priming nor maturation
of DCs was required prior to transfer to induce autoimmunity.
However, our ability to induce autoimmunity was dependent
on the age of the recipient mouse. Histological evidence of
pancreatitis was only seen when Tgfbr2
fspKO DCs were
transferred to 2-week-old mice; transfer of Tgfbr2
fspKO DCs to
adult mice did not induce pancreatitis. Similarly, Tgfbr2
fspKO
mice had no gross phenotypic abnormalities or pancreatic
inflammation by histology until after 2 weeks of age.
Interestingly, the second postnatal week has previously been
identified as a critical time for the development of pancreatic
autoimmunity in the form of IDDM.
21 During this time, the
pancreas undergoes a developmental rearrangement that results
in a wave of programmed cell death involving both exocrine and
endocrine pancreatic tissue (personal communication).
22 So, it
remains unclear why Tgfbr2
fspKO mice develop autoimmunity of
the exocrine but not the endocrine pancreas. However, non-
obese diabetic (NOD) mice are known to have increased cell
death within the endocrine pancreas compared with normal
mice.
23 It is possible that the digestive enzymes present within
pancreatic acinar cells may provide for a more pronounced
inflammatory environment compared with the endocrine
pancreas. Alternatively, by using the S100A4 promoter to
disrupt TGFb signalling, we have targeted a unique DC
population with specific functional properties or a specific stage
of DC maturation. Antigen-presenting cells, including DCs,
recruited to remove the resulting cellular debris of the develop-
mental rearrangement are exposed to large amounts of self-
antigens, and abnormal DC maturation in response to antigens
can lead to autoimmunity.
24 It is likely that mAIP results in
Tgfbr2
fspKO mice through a similar mechanism involving abnormal
DC maturation in response to exocrine pancreatic antigens.
Consistent with our results, lack of TGFb regulation has
previously been implicated in histological changes associated
with mAIP.
25 Mice overexpressing a dominant-negative form of
Tgfbr2 directed by the pS2 mouse trefoil peptide promoter to
target pancreatic acinar cells (pS2-dnRII) developed mAIP after
cerulein treatment. Cerulein is a cholecystokinin analogue that
induces cell death in exocrine pancreatic tissue at supraphysio-
logical doses. PS2-dnRII mice do not spontaneously develop
mAIP, and it is likely that cerulein treatment in combination
with the loss of TGFb signalling is required to induce an
inflammatory milieu sufficient to overcome the normal DC
tolerogenic mechanisms present in pS2-dnRII mice.
Upregulation of MHC class II in pancreatic acini expressing
dnRII was associated with mAIP in the PS2-dnRII mice.
Analogously, the mAIP observed in Tgfbr2
fspKO mice was
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Tgfbr2
fspKO DCs, supporting TGFb regulation of MHC class II
expression in maintaining immune tolerance. The upregulation
of MHC class II alone in PS2-dnRII was not sufficient for
pathogenesis of mAIP, as cerulein treatment was required. This
is probably due to the inflammatory milieu induced by cerulein
that is necessary for the production of co-stimulatory signals
needed for T cell activation that are not produced by pancreatic
acini. mAIP spontaneously develops in Tgfbr2
fspKO mice because
DCs also upregulate co-stimulatory molecule expression (eg,
CD86) along with MHC class II. Since Tgfbr2
fspKO mice lack
normal DC regulation of both MHC class II and co-stimulatory
molecules, the antigens released due to cell death resulting from
the pancreatic developmental rearrangement in Tgfbr2
fspKO
mice, or 2-week-old wild-type mice receiving Tgfbr2
fspKO DCs, is
sufficient to induce pancreatitis in these mice. This would explain
why adult wild-type mice receiving Tgfbr2
fspKO DCs do not
develop pancreatitis, as the required inciting developmental event
has passed. If true, cerulein treatment of adult wild-type mice
receiving Tgfbr2
fspKO DCs may induce mAIP. The spontaneous
development of mAIP in Tgfbr2
fspKO mice is probably a
combinatorial effect of a developmentally induced apoptotic
wave and altered regulation of Tgfbr2
fspKO DC tolerance.
Our finding that loss of immune tolerance in myeloid
S100A4
+ DCs can mediate mAIP in mice may help to explain
some pathogenic aspects of human AIP, an IgG4-related
sclerosing disease. However, differences exist between the
mAIP disease model and the human condition. The lack of
pancreatic fibrosis in diseased Tgfbr2
fspKO pancreata is likely to
be due to the inability of fibroblasts in the transgenic mouse to
respond to TGFb, a potent mediator of collagen expression.
26
The development of mAIP occurs in mice of both genders early
in life, whereas human AIP typically affects older males.
2 It also
remains unclear why our Tgfbr2
fspKO mice have involvement of
some of the organs seen in IgG4-related sclerosing disease,
including pancreas and salivary gland involvement, but not
other organs such as lung or kidney. One explanation may lie in
the fact that mice do not express the IgG4 subclass.
25 We are
hopeful that further work utilising our murine model will lead
to a better understanding of disease pathogenesis in AIP.
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